Skip to main content
Clinical Trials/NCT02035436
NCT02035436CompletedNot Applicable

Substudy of the NONSEDA Trial (NCT01967680): Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Me-chanical Ventilation - Effects on Cognitive Function

Palle Toft1 site in 1 country205 target enrollmentStarted: January 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
205
Locations
1
Primary Endpoint
Cognitive function

Study Overview

Brief Summary

Through many years, the standard care has been to use continuous sedation of critically ill patients during mechanical ventilation. However, preliminary randomised clinical trials indicate that it is beneficial to reduce the sedation level in these patients. The NONSEDA trial is an investigator-initiated, randomised, clinical, parallel-group, multinational, superiority trial designed to include 700 patients from at least six ICUs in Denmark, Norway and Sweden, comparing no sedation with sedation and a daily wake-up trial during mechanical ventilation. This is a substudy of the NONSEDA trial, concerning 250 patients included at trialsite Kolding, Denmark. The aim of the substudy is to assess the effects of no sedation on delirium during admission and cognitive function after discharge from ICU.

Our hypothesis is that critically ill patients who are not sedated during mechanical ventilation will have better cognitive function after discharge.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Endotracheally intubated
  • •Expected time on ventilator > 24 hours
  • •Age ≥ 18 years
  • •Informed consent

Exclusion Criteria

  • •Severe head trauma where therapeutic coma is indicated
  • •Therapeutic hypothermia where therapeutic coma is indicated
  • •Status epilepticus where therapeutic coma is indicated
  • •Patient has participated in the study before
  • •Patient is transferred from another ICU with length of stay > 48 hours
  • •Patient is comatose at admission
  • •PaO2/FiO2 ≤ 9, if sedation is necessary for oxygenation
  • •Patient does not speak Danish, swedish or norwegian at a reasonable level

Arms & Interventions

Non-sedation

Experimental

Non-sedation supplemented with pain management during mechanical ventilation.

Intervention: Non-sedation (Other)

Sedation

Active Comparator

Current gold standard: Sedation with a daily wake-up trial.

Intervention: Control: Sedation (Other)

Outcomes

Primary Outcomes

Cognitive function

Time Frame: 3 months after discharge from ICU

Cognitive t-score, in percentage, difference between the two groups. The t-score for each patient will be diagnosed by the neuropsycologist at a personal interview and use of following tests: * Span of numbers * Coding test * Trailmaking A+B * Rey auditory verbal learning test (immediate, recall) * Rey-Ostherrieth complex figure test (immediate, recall, recognition) * Word finding test (S-word, animals) * Stroop test (congruent+incongruent)

Secondary Outcomes

  • Attention/concentration(3 months after discharge from ICU)
  • Learning/memory(3 months after discharge from ICU)
  • Executive dysfunction(3 months after discharge from ICU)
  • Agitated delirium(3 months after discharge from ICU)
  • Mental pace(3 months after discharge from ICU)
  • Hypoactive delirium(3 months after discharge from ICU)

Investigators

Sponsor
Palle Toft
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Palle Toft

Professor

Odense University Hospital

Study Sites (1)

Loading locations...

Similar Trials